These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12926121)

  • 1. Loss of Fhit protein expression in high-grade and advanced stage endometrial carcinomas.
    Yura Y; Mandai M; Konishi I; Hamid AA; Tsuruta Y; Kusakari T; Fujii S
    Anticancer Res; 2003; 23(3C):2837-43. PubMed ID: 12926121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
    Segawa T; Sasagawa T; Saijoh K; Inoue M
    Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fhit protein expression in endometrial cancers: no correlation with histological grade.
    Hadaczek P; Gronwald J; Chosia M; Huebner K; Lubiński J
    Pol J Pathol; 2001; 52(4):199-203. PubMed ID: 11915181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma.
    Yang Q; Yoshimura G; Suzuma T; Tamaki T; Umemura T; Nakamura M; Nakamura Y; Wang X; Mori I; Sakurai T; Kakudo K
    Clin Cancer Res; 2001 Dec; 7(12):3869-73. PubMed ID: 11751477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
    Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease.
    Campiglio M; Pekarsky Y; Menard S; Tagliabue E; Pilotti S; Croce CM
    Cancer Res; 1999 Aug; 59(16):3866-9. PubMed ID: 10463571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletions of BRCA1/2 and p53 R248W gain-of-function mutation suggest impaired homologous recombination repair in fragile histidine triad-negative sebaceous gland carcinomas.
    Becker K; Goldberg M; Helmbold P; Holbach LM; Loeffler KU; Ballhausen WG
    Br J Dermatol; 2008 Dec; 159(6):1282-9. PubMed ID: 18717684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
    Yao CC; Lin CY; Hu MB
    Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines.
    Hendricks DT; Taylor R; Reed M; Birrer MJ
    Cancer Res; 1997 Jun; 57(11):2112-5. PubMed ID: 9187105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
    Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
    Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal fragile histidine triad (Fhit) expression in invasive cervical adenocarcinoma: association with tumor aggressiveness.
    Yoon SO
    Hum Pathol; 2007 Feb; 38(2):326-31. PubMed ID: 17137614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FHIT RNA and protein expression in oral squamous cell carcinomas.
    van Heerden WF; Swart TJ; Robson B; Smith TL; Engelbrecht S; van Heerden MB; van Rensburg EJ; Huebner K
    Anticancer Res; 2001; 21(4A):2425-8. PubMed ID: 11724302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
    Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
    Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression.
    Nanbu K; Konishi I; Komatsu T; Mandai M; Yamamoto S; Kuroda H; Koshiyama M; Mori T
    Cancer; 1996 Jan; 77(2):330-8. PubMed ID: 8625242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.
    Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of the fragile histidine triad transcription protein expression in laryngeal carcinogenesis.
    Kitamura K; Hayashi K; Kobayashi R; Ishii H; Matsubayashi J; Matsumoto T; Suzuki M
    Oncol Rep; 2008 Apr; 19(4):847-52. PubMed ID: 18357366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: a poor prognostic factor.
    Krivak TC; McBroom JW; Seidman J; Venzon D; Crothers B; MacKoul PJ; Rose GS; Carlson JW; Birrer MJ
    Cancer Res; 2001 Jun; 61(11):4382-5. PubMed ID: 11389064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas.
    Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH
    Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.